Mar. 19 at 11:25 AM
$AVAH Aveanna sees FY26 revenue
$2.54B-
$2.56B, consensus
$2.56B
Matt Buckhalter, Chief Financial Officer, commented, "2025 was a monumental year for Aveanna. Our team delivered exceptional performance across the business, generating annual revenue growth of 20.2% and Adjusted EBITDA growth of 74.8%. These results reflect the strength of our clinical model, the dedication of our caregivers, and the disciplined execution of our strategy across each of our segments. We also generated
$131.0 million in free cash flow during the year, further strengthening our balance sheet and providing additional flexibility to invest in the continued growth at Aveanna. In line with customary practice, we have not included our pending acquisition in our full-year 2026 guidance. We continue to maintain our guidance for 2026 of revenue between
$2.54 and
$2.56 billion and Adjusted EBITDA between
$318 and
$322 million."
